Le Lézard
Classified in: Health, Business
Subject: CXP

Ribbon-Cutting Held for Treatment Clinic That's Transforming Lives


SAN DIEGO, March 22, 2018 /PRNewswire/ -- Community members and addiction treatment professionals gathered at San Diego Addiction Treatment Center on March 22, 2018, for a ribbon-cutting ceremony to celebrate the facility's grand opening. With drug overdose being the leading cause of death for Americans under 50, San Diego Addiction Treatment Center is a lifeline for those in San Diego and beyond.

San Diego Addiction Treatment Center CEO, Gil Carmona, and American Addiction Centers' President and COO, Michael Nanko, are joined by SDATC staff and representatives from the San Diego Regional Chamber of Commerce.

San Diego Addiction Treatment Center, an American Addiction Centers' facility, is one of the first gender-specific outpatient treatment clinics in San Diego that provides research-based clinical and support services for adult males struggling with drug addictions and co-occurring mental health disorders. In San Diego County alone, males accounted for 66 percent of overdose deaths in 2016.

"I am thrilled to be the CEO of this new facility that is truly transforming lives and bringing a much-needed service to our community," said Gil Carmona, CEO of San Diego Addiction Treatment Center. "For those who are at a point in their recovery journey where they need outpatient services, this facility makes it possible for them to get high-quality treatment that fits their lifestyle."

While the standalone facility only offers outpatient services, it is part of Laguna Treatment Hospital's continuum of care which provides individuals with a seamless, coordinated transition of care from medical detox down to outpatient services and transitional living.

"Maintaining long-term sobriety is possible," said Sean O'Neil, director of outpatient services at San Diego Addiction Treatment Center. "With our individualized treatment and aftercare plans, we ensure individuals have the support and resources they need to thrive."

San Diego Addiction Treatment Center also offers transitional supportive housing at Resolutions San Diego.

For more information or a referral to San Diego Addiction Treatment Center, contact Regional Manager Lisa Martz at 619-972-1929 or visit sdtreatmentcenter.com.

Press Contact:
Joy Sutton, Public Relations Manager
American Addiction Centers
Mobile: (615) 587-7728  
[email protected]

Yasmeen Garcia, Public Relations Assistant
Recovery Brands
[email protected]

Gil Carmona, CEO
San Diego Addiction Treatment Center
Phone: (951) 401 0138
[email protected]

 

SOURCE San Diego Addiction Treatment Center


These press releases may also interest you

at 17:48
Hundreds of Community Leaders Kick Off Multi-city Convening in Bakersfield With a Simple Message: Do Not Cut San Joaquin Valley Programs & Services
On Wednesday, April 17, the San Joaquin Valley Health Fund (SJVHF) launched "Equity on the Road" a multi-city series of community town halls to deepen local understanding of state issues and to advocate for more resources in the San Joaquin Valley....

at 17:44
NOTICE TO THE MEDIA - Minister Holland to highlight Budget 2024: Fairness for Every Generation investments in students
The Honourable Mark Holland, Minister of Health, will host an event at the University of Waterloo to highlight the federal budget's investments to support students. The Minister will be joined by Bryan May, Parliamentary Secretary to the Minister of...

at 17:31
Global Radioimmunoassay Market to Grow at a Minimal CAGR of ~3% by 2030 | DelveInsight
The increasing need for radioimmunoassay is mainly driven by the rising occurrence of cancer, infectious diseases, and various other health conditions, along with a growing number of epidemics and pandemics and increasing health awareness. Moreover,...

at 17:00
Avicanna Announces Closing of Non-brokered Private Placement
Avicanna Inc. ("Avicanna" or the "Company") a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based products is pleased to announce that it has closed a non-brokered private...

at 16:46
Darling Ingredients Inc. to Release First Quarter 2024 Financial Results
Darling Ingredients Inc. announced today that it will host a conference call on Thursday, April 25, 2024, at 9 a.m. Eastern Time (8 a.m. Central Time) to discuss first quarter 2024 financial results, which will be released earlier that day, and...

at 16:45
FDA Approves Genentech's Alecensa as First Adjuvant Treatment for People With ALK-Positive Early-Stage Lung Cancer
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the U.S. Food and Drug Administration (FDA) has approved Alecensa® (alectinib) for adjuvant treatment following tumor resection for patients with anaplastic...

More news about Health...


News published on and distributed by: